Avenacy debuts generic LasixFurosemide is indicated in adults and pediatric patients for the treatment of edema associated with congestive heart failure, cirrhosis of the liver and renal disease. NACDS RxIMPACT announces 2024 Grassroots awardsDuring the dinner program, NACDS Chair Mike Wysong, CEO of CARE Pharmacies, and NACDS president and CEO Steve Anderson presented the awards. Insud Pharma acquires Viatris' women's healthcare business The women’s healthcare business is primarily related to oral and injectable contraceptives. Novo Nordisk gets FDA OK for new indication for Wegovy Wegovy is now indicated to reduce the risk of serious heart problems in overweight or obese adults. Camber debuts generic Gralise Camber’s generic Gralise tablets are indicated for the management of Postherpetic Neuralgia. Lupin appoints Rakesh Bhardwaj as chief information officer Bhardwaj will lead Lupin’s global information technology function and spearhead the company’s digital transformation. Retail pharmacy searches for its top model Retail pharmacy is seeking changes to the business, but what will be the ideal model? Jeff Needham receives CHPA’s Ivan D. Combe Lifetime Achievement Award The Ivan D. Combe Lifetime Achievement Award is the highest honor bestowed by the U.S. consumer healthcare industry. Avenacy launches 2 new generics Avenacy is offering two new products, Fosaprepitant for Injection, which is the generic of Emend, and Fulvestrant Injection, which is the generic of Foslodex. CVS Health CEO Karen Lynch weighs in on health issues on CVS Evening News with Norah O’Donnell CVS Health's Karen Lynch addressed questions on abortion pills available in store, the politics of health care and retail crime. First Previous 55 56 57 58 59 Next Last